These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 1572445

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Efficacy of sublingual immunotherapy in children with asthma and rhinitis: a double-blind, placebo-controlled study.
    Bahçeciler NN, Işik U, Barlan IB, Başaran MM.
    Pediatr Pulmonol; 2001 Jul; 32(1):49-55. PubMed ID: 11416876
    [Abstract] [Full Text] [Related]

  • 23. Effects of pranlukast on chemical mediators in induced sputum on provocation tests in atopic and aspirin-intolerant asthmatic patients.
    Obase Y, Shimoda T, Tomari SY, Mitsuta K, Kawano T, Matsuse H, Kohno S.
    Chest; 2002 Jan; 121(1):143-50. PubMed ID: 11796443
    [Abstract] [Full Text] [Related]

  • 24. Immunotherapy by inhalation of allergen in powder in house dust allergic asthma--a double-blind study.
    Tari MG, Mancino M, Monti G.
    J Investig Allergol Clin Immunol; 1992 Jan; 2(2):59-67. PubMed ID: 1342886
    [Abstract] [Full Text] [Related]

  • 25. Effect of one-year subcutaneous and sublingual immunotherapy on clinical and laboratory parameters in children with rhinitis and asthma: a randomized, placebo-controlled, double-blind, double-dummy study.
    Yukselen A, Kendirli SG, Yilmaz M, Altintas DU, Karakoc GB.
    Int Arch Allergy Immunol; 2012 Jan; 157(3):288-98. PubMed ID: 22041501
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Significant improvement of specific bronchial hyperreactivity in asthmatic children after 4 months of treatment with a modified extract of dermatophagoides pteronyssinus.
    Ibero M, Castillo MJ.
    J Investig Allergol Clin Immunol; 2006 Jan; 16(3):194-202. PubMed ID: 16784014
    [Abstract] [Full Text] [Related]

  • 28. Non-allergic bronchial hyperreactivity in asthmatic children decreases with age and increases with mite immunotherapy.
    Murray AB, Ferguson AC, Morrison BJ.
    Ann Allergy; 1985 Jun; 54(6):541-4. PubMed ID: 4014783
    [Abstract] [Full Text] [Related]

  • 29. SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma.
    Blumberga G, Groes L, Dahl R.
    Allergy; 2011 Feb; 66(2):178-85. PubMed ID: 20883456
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Clinico-immunologic characteristics of mite-borne bronchial asthma].
    Vaĭtsekauskaĭte RL, Kanchurin AKh, Razgauskas EF, Berzhets VM.
    Ter Arkh; 1988 Feb; 60(10):97-9. PubMed ID: 3222756
    [Abstract] [Full Text] [Related]

  • 32. Histamine in late asthmatic reactions following house-dust mite inhalation.
    de Monchy JG, Keyzer JJ, Kauffman HF, Beaumont F, de Vries K.
    Agents Actions; 1985 Apr; 16(3-4):252-5. PubMed ID: 4013914
    [Abstract] [Full Text] [Related]

  • 33. Clinical effectiveness of a mite allergen-impermeable bed-covering system in asthmatic mite-sensitive patients.
    van den Bemt L, van Knapen L, de Vries MP, Jansen M, Cloosterman S, van Schayck CP.
    J Allergy Clin Immunol; 2004 Oct; 114(4):858-62. PubMed ID: 15480327
    [Abstract] [Full Text] [Related]

  • 34. A 1-year, placebo-controlled, double-blind house-dust-mite immunotherapy study in asthmatic adults.
    Olsen OT, Larsen KR, Jacobsan L, Svendsen UG.
    Allergy; 1997 Aug; 52(8):853-9. PubMed ID: 9284985
    [Abstract] [Full Text] [Related]

  • 35. In vitro T-lymphocyte response and house dust mite-induced bronchoconstriction.
    Chang JH, Chan H, Quirce S, Green T, Noertjojo K, Lam S, Frew A, Keown P, Chan-Yeung M.
    J Allergy Clin Immunol; 1996 Nov; 98(5 Pt 1):922-31. PubMed ID: 8939155
    [Abstract] [Full Text] [Related]

  • 36. [The effect of local specific bronchial immunotherapy (LIT) on specific and non-specific bronchial hyperreactivity in patients with bronchial asthma sensitive to housedust mites].
    Zietkowski Z, Rogalewska AM, Bodzenta-ŁLukaszyk A.
    Pol Merkur Lekarski; 2000 Oct; 9(52):645-7. PubMed ID: 11144048
    [Abstract] [Full Text] [Related]

  • 37. Increase in allergen-specific IgE and ex vivo Th2 responses after a single bronchial challenge with house dust mite in allergic asthmatics.
    van de Pol MA, Lutter R, van Ree R, van der Zee JS.
    Allergy; 2012 Jan; 67(1):67-73. PubMed ID: 21958117
    [Abstract] [Full Text] [Related]

  • 38. Hyposensitization in asthmatics with mPEG modified and unmodified house dust mite extract. II. Effect evaluated by challenges with allergen and histamine.
    Mosbech H, Dreborg S, Frølund L, Ljungstedt-Påhlman I, Svendsen UG, Søborg M, Taudorf E, Weeke B.
    Allergy; 1989 Sep; 44(7):499-509. PubMed ID: 2817306
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Effect of a bed covering system in children with asthma and house dust mite hypersensitivity.
    Frederick JM, Warner JO, Jessop WJ, Enander I, Warner JA.
    Eur Respir J; 1997 Feb; 10(2):361-6. PubMed ID: 9042633
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.